- Home
- MDIA vs CLSD Comparison
MDIA vs CLSD Comparison
Compare MDIA & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDIA
- CLSD
- Stock Information
- Founded
- MDIA 2019
- CLSD 2011
- Country
- MDIA United States
- CLSD United States
- Employees
- MDIA N/A
- CLSD N/A
- Industry
- MDIA Broadcasting
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- MDIA Consumer Discretionary
- CLSD Health Care
- Exchange
- MDIA Nasdaq
- CLSD Nasdaq
- Market Cap
- MDIA 51.8M
- CLSD 59.1M
- IPO Year
- MDIA N/A
- CLSD 2016
- Fundamental
- Price
- MDIA $1.28
- CLSD $0.83
- Analyst Decision
- MDIA
- CLSD Strong Buy
- Analyst Count
- MDIA 0
- CLSD 4
- Target Price
- MDIA N/A
- CLSD $4.75
- AVG Volume (30 Days)
- MDIA 708.1K
- CLSD 189.9K
- Earning Date
- MDIA 05-20-2025
- CLSD 08-11-2025
- Dividend Yield
- MDIA N/A
- CLSD N/A
- EPS Growth
- MDIA N/A
- CLSD N/A
- EPS
- MDIA N/A
- CLSD N/A
- Revenue
- MDIA $116,895,000.00
- CLSD $3,764,000.00
- Revenue This Year
- MDIA N/A
- CLSD $143.33
- Revenue Next Year
- MDIA N/A
- CLSD N/A
- P/E Ratio
- MDIA N/A
- CLSD N/A
- Revenue Growth
- MDIA 268.03
- CLSD N/A
- 52 Week Low
- MDIA $0.79
- CLSD $0.70
- 52 Week High
- MDIA $5.73
- CLSD $1.65
- Technical
- Relative Strength Index (RSI)
- MDIA 55.60
- CLSD 50.39
- Support Level
- MDIA $1.18
- CLSD $0.78
- Resistance Level
- MDIA $1.38
- CLSD $0.90
- Average True Range (ATR)
- MDIA 0.12
- CLSD 0.04
- MACD
- MDIA 0.01
- CLSD 0.00
- Stochastic Oscillator
- MDIA 53.75
- CLSD 44.15
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.